A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder
Conditions
Generalized Anxiety Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
SLaM, London, United Kingdom
Contact: Study coordinator (Principal Investigator)
Study leads
Allan Young
Principal Investigator
SLaM